# BIBX 1382 in Treating Patients With Solid Tumors

> **NCT00003980** · PHASE1 · SUSPENDED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 80 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** BIBX 1382

## Key facts

- **NCT ID:** NCT00003980
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 1999-02
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003980, "BIBX 1382 in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*